Dr Dena Jones Howell, MD in Mobile, AL - Medicare Dermatology

Dr Dena Jones Howell, MD is a medicare enrolled "Dermatology" physician in Mobile, Alabama. She went to University Of Mississippi School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice The Center For Dermatology, P.c and her current practice location is 4310 Old Shell Rd, Suite D, Mobile, Alabama. You can reach out to her office (for appointments etc.) via phone at (251) 343-9100.

Dr Dena Jones Howell is licensed to practice in Alabama (license number 00027283) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1013970284.

Contact Information

	Dr Dena Jones Howell, MD
	4310 Old Shell Rd, Suite D, Mobile, AL 36608-2049
	(251) 343-9100
	(251) 343-9125

Physician's Profile

Full Name	Dr Dena Jones Howell
Gender	Female
Speciality	Dermatology
Experience	24 Years
Location	4310 Old Shell Rd, Mobile, Alabama
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Dena Jones Howell attended and graduated from University Of Mississippi School Of Medicine in 2000

NPI Data:

NPI Number: 1013970284
Provider Enumeration Date: 04/10/2006
Last Update Date: 11/20/2013

Medicare PECOS Information:

PECOS PAC ID: 5496767543
Enrollment ID: I20060608000135

Medical Identifiers

Medical identifiers for Dr Dena Jones Howell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013970284	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	00027283 (Alabama)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
The Center For Dermatology, P.c	6406868546	5

News Archive

South Korea considering food assistance for North Korea, official says

"Signaling South Korea may be attempting to cool tensions with its neighbor, Seoul has vowed to actively review sending humanitarian aid to North Korea through third channels," CNN reports.

Gene mutations found to predict acute lymphoblastic leukemia relapse

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL).

Researchers take major step forward in understanding causes of CRPS

Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange announced today the successful results of the Phase 1/2 study of its drug candidate CF102 in the treatment of hepatocellular carcinoma.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Dena Jones Howell allows following entities to bill medicare on her behalf.

Entity Name	The Center For Dermatology, P.c>
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1316914583 PECOS PAC ID: 6406868546 Enrollment ID: O20060608000120

News Archive

South Korea considering food assistance for North Korea, official says

"Signaling South Korea may be attempting to cool tensions with its neighbor, Seoul has vowed to actively review sending humanitarian aid to North Korea through third channels," CNN reports.

Gene mutations found to predict acute lymphoblastic leukemia relapse

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL).

Researchers take major step forward in understanding causes of CRPS

Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dena Jones Howell is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Dena Jones Howell, MD 4310 Old Shell Rd, Suite D, Mobile, AL 36608-2049 Ph: (251) 343-9100	Dr Dena Jones Howell, MD 4310 Old Shell Rd, Suite D, Mobile, AL 36608-2049 Ph: (251) 343-9100

News Archive

South Korea considering food assistance for North Korea, official says

"Signaling South Korea may be attempting to cool tensions with its neighbor, Seoul has vowed to actively review sending humanitarian aid to North Korea through third channels," CNN reports.

Gene mutations found to predict acute lymphoblastic leukemia relapse

Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL).

Researchers take major step forward in understanding causes of CRPS

Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Dermatology Doctors in Mobile, AL

Virginia Jones Reeder, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E, 2nd Floor, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572
Dr. John Scott Vanloock, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6163 Omni Park Dr, Mobile, AL 36609 Phone: 251-635-1315 Fax: 251-635-1210
Dr. Robert Neil Capper, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 5317 Oak Bend Ct, Mobile, AL 36609 Phone: 251-661-3200
Aldo Trovato, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3715 Dauphin Street Building 2, 4th Floor, Mobile, AL 36608 Phone: 251-343-2100 Fax: 251-344-9944
Dr. Ryan Burke Ramagosa, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 70 Midtown Park E, Mobile, AL 36606 Phone: 251-289-1786
Dr. Cary L. Dunn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Providence Park Dr E Fl 2, Mobile, AL 36695 Phone: 251-631-3570 Fax: 251-631-3572

Dr Dena Jones Howell, MD - Medicare Dermatology in Mobile, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

South Korea considering food assistance for North Korea, official says

Gene mutations found to predict acute lymphoblastic leukemia relapse

Researchers take major step forward in understanding causes of CRPS

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Medicare Reassignments

South Korea considering food assistance for North Korea, official says

Gene mutations found to predict acute lymphoblastic leukemia relapse

Researchers take major step forward in understanding causes of CRPS

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

South Korea considering food assistance for North Korea, official says

Gene mutations found to predict acute lymphoblastic leukemia relapse

Researchers take major step forward in understanding causes of CRPS

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Dermatology Doctors in Mobile, AL